Primary Health Properties PLC (PHP.L) Stock Price Target and Analyst Ratings (LON:PHP)

Analyst Price Target for PHP

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

GBX 168

▲ +10.53% Upside Potential

This price target is based on 5 analysts offering 12 month price targets for Primary Health Properties PLC (PHP.L) in the last 3 months. The average price target is GBX 168, with a high forecast of GBX 175 and a low forecast of GBX 155. The average price target represents a 10.53% upside from the last price of GBX 152.

Buy

The current consensus among 5 contributing investment analysts is to buy stock in Primary Health Properties PLC (PHP.L). This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
1 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

9/5/2019

0 strong buy ratings
2 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

12/4/2019

0 strong buy ratings
3 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

3/3/2020

0 strong buy ratings
3 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

6/1/2020

0 strong buy ratings
3 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

8/30/2020

0 strong buy ratings
3 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

11/28/2020

0 strong buy ratings
3 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

1/27/2021

0 strong buy ratings
3 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

2/26/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Details
2/17/2021	Jefferies Financial Group	Boost Price Target	Buy	GBX 168 ➝ GBX 172	i
7/29/2020	Peel Hunt	Reiterated Rating	Add		i
7/29/2020	Liberum Capital	Reiterated Rating	Buy		i
7/14/2020	Berenberg Bank	Downgrade	Hold	GBX 150 ➝ GBX 155	i
7/9/2020	Liberum Capital	Reiterated Rating	Buy		i
7/9/2020	Peel Hunt	Reiterated Rating	Restricted		i
5/28/2020	Peel Hunt	Reiterated Rating	Add		i
5/11/2020	Liberum Capital	Reiterated Rating	Buy		i
5/6/2020	Berenberg Bank	Reiterated Rating	Buy		i
5/6/2020	Peel Hunt	Boost Price Target	Add	GBX 160 ➝ GBX 175	i
4/15/2020	Peel Hunt	Reiterated Rating	Add		i
4/15/2020	Barclays	Reiterated Rating	Overweight	GBX 168 ➝ GBX 170	i
4/2/2020	Jefferies Financial Group	Upgrade	Buy	GBX 165 ➝ GBX 179	i
4/1/2020	Peel Hunt	Reiterated Rating	Add		i
4/1/2020	Liberum Capital	Reiterated Rating	Buy		i
3/25/2020	Berenberg Bank	Upgrade	Buy		i
3/18/2020	Peel Hunt	Reiterated Rating	Add		i
3/12/2020	Peel Hunt	Reiterated Rating	Add		i
2/13/2020	Barclays	Reiterated Rating	Overweight	GBX 160 ➝ GBX 168	i
2/12/2020	Peel Hunt	Reiterated Rating	Add	GBX 160	i
2/12/2020	Liberum Capital	Reiterated Rating	Buy		i
2/11/2020	Peel Hunt	Reiterated Rating	Add	GBX 160	i
2/5/2020	Peel Hunt	Reiterated Rating	Add		i
2/5/2020	Liberum Capital	Reiterated Rating	Buy		i
1/27/2020	Liberum Capital	Upgrade	Buy	GBX 130 ➝ GBX 185	i
1/17/2020	Jefferies Financial Group	Downgrade	Hold	GBX 147 ➝ GBX 155	i
1/14/2020	Peel Hunt	Reiterated Rating	Add		i
1/7/2020	Peel Hunt	Reiterated Rating	Add		i
12/17/2019	Peel Hunt	Boost Price Target	Add	GBX 145 ➝ GBX 160	i
12/13/2019	Jefferies Financial Group	Reiterated Rating	Buy		i
12/6/2019	Liberum Capital	Reiterated Rating	Hold		i
12/3/2019	Barclays	Initiated Coverage	Overweight	GBX 160	i
12/3/2019	Peel Hunt	Reiterated Rating	Add		i
11/29/2019	Berenberg Bank	Initiated Coverage	Hold	GBX 150	i
11/26/2019	Peel Hunt	Reiterated Rating	Add		i
11/25/2019	Liberum Capital	Reiterated Rating	Hold		i
11/5/2019	Peel Hunt	Reiterated Rating	Add		i
10/22/2019	Peel Hunt	Reiterated Rating	Add		i
10/15/2019	Peel Hunt	Reiterated Rating	Add		i
10/7/2019	Peel Hunt	Reiterated Rating	Add		i
9/26/2019	Peel Hunt	Reiterated Rating	Add		i
9/24/2019	Liberum Capital	Reiterated Rating	Hold		i
9/17/2019	Peel Hunt	Reiterated Rating	Add		i
9/10/2019	Peel Hunt	Reiterated Rating	Add		i
8/27/2019	Peel Hunt	Reiterated Rating	Add		i
8/20/2019	Liberum Capital	Reiterated Rating	Hold		i
8/9/2019	Peel Hunt	Reiterated Rating	Add		i
7/25/2019	Liberum Capital	Reiterated Rating	Hold		i
7/22/2019	Peel Hunt	Reiterated Rating	Add		i
7/15/2019	Peel Hunt	Reiterated Rating	Add		i
7/9/2019	Peel Hunt	Reiterated Rating	Add		i
6/25/2019	Peel Hunt	Reiterated Rating	Add		i
6/17/2019	Peel Hunt	Downgrade	Add	GBX 140 ➝ GBX 145	i
6/11/2019	Peel Hunt	Reiterated Rating	Buy		i
6/4/2019	Peel Hunt	Reiterated Rating	Buy		i
5/28/2019	Peel Hunt	Reiterated Rating	Buy		i
5/14/2019	Peel Hunt	Upgrade	Buy		i
5/8/2019	Peel Hunt	Upgrade	Buy		i
3/25/2019	Liberum Capital	Downgrade	Hold	GBX 125 ➝ GBX 130	i
3/15/2019	Peel Hunt	Reiterated Rating	Under Review		i
1/14/2019	Peel Hunt	Reiterated Rating	Buy		i
1/9/2019	Liberum Capital	Reiterated Rating	Buy		i
1/4/2019	Peel Hunt	Reiterated Rating	Buy		i
12/20/2018	Peel Hunt	Reiterated Rating	Buy		i
12/17/2018	Liberum Capital	Reiterated Rating	Buy		i
12/5/2018	Liberum Capital	Reiterated Rating	Buy		i
10/30/2018	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
10/22/2018	Liberum Capital	Reiterated Rating	Buy		i
9/19/2018	Peel Hunt	Reiterated Rating	Buy		i
9/5/2018	Peel Hunt	Reiterated Rating	Buy		i
9/5/2018	Liberum Capital	Reiterated Rating	Buy		i
7/25/2018	Peel Hunt	Reiterated Rating	Buy		i
7/25/2018	Liberum Capital	Upgrade	Buy		i
7/12/2018	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
6/11/2018	Peel Hunt	Reiterated Rating	Buy		i
5/9/2018	Peel Hunt	Reiterated Rating	Buy		i
5/2/2018	Liberum Capital	Upgrade	Hold	GBX 120	i
4/30/2018	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
4/23/2018	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
3/23/2018	Liberum Capital	Reiterated Rating	Hold	GBX 120	i
2/21/2018	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
2/15/2018	Liberum Capital	Reiterated Rating	Hold	GBX 120	i
2/15/2018	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
1/18/2018	Jefferies Financial Group	Reiterated Rating	Buy	GBX 126	i
1/8/2018	Liberum Capital	Reiterated Rating	Hold	GBX 120	i
1/2/2018	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
12/14/2017	Liberum Capital	Reiterated Rating	Hold	GBX 120	i
12/5/2017	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
11/29/2017	Jefferies Financial Group	Initiated Coverage	Buy	GBX 125	i
8/2/2017	Liberum Capital	Reiterated Rating	Hold	GBX 120	i
7/27/2017	Liberum Capital	Reiterated Rating	Hold	GBX 120	i
7/27/2017	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
4/20/2017	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
4/20/2017	Liberum Capital	Reiterated Rating	Hold	GBX 110	i
3/13/2017	Liberum Capital	Lower Price Target	Hold	GBX 120 ➝ GBX 110	i
2/16/2017	Liberum Capital	Reiterated Rating	Hold	GBX 120	i
2/16/2017	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
2/3/2017	Liberum Capital	Reiterated Rating	Hold	GBX 120	i
11/1/2016	Liberum Capital	Reiterated Rating	Hold	GBX 120	i
7/27/2016	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
7/27/2016	Liberum Capital	Reiterated Rating	Hold	GBX 112	i
7/20/2016	Peel Hunt	Reiterated Rating	Buy	GBX 125	i
7/4/2016	Liberum Capital	Reiterated Rating	Hold	GBX 112	i
5/20/2016	Peel Hunt	Reiterated Rating	Buy		i
4/27/2016	Liberum Capital	Reiterated Rating	Hold		i
4/15/2016	Peel Hunt	Reiterated Rating	Buy		i
3/22/2016	Liberum Capital	Reiterated Rating	Hold		i

(Data available from 2/27/2016 forward)

Primary Health Properties (PHP) is the leading investor in modern healthcare properties in the UK & Ireland. PHP is a UK based Real Estate Investment Trust (REIT) with a clear objective to create progressive returns to shareholders through a combination of earnings growth and capital appreciation. PHP achieve this by investing in healthcare real estate let on long-term leases, backed by a secure underlying covenant funded mostly by government bodies. The Group's portfolio comprises over 480 primary healthcare facilities, both completed and committed, the majority of which are GP surgeries, with other properties let to NHS organisations, pharmacies and dentists.

Today's Range

Now: GBX 152

150.60

153.20

50 Day Range

MA: GBX 148.91

145.20

157.40

52 Week Range

Now: GBX 152

120.40

167.60

Volume

5,241,876 shs

Average Volume

3,959,096 shs

Market Capitalization

£2.02 billion

P/E Ratio

17.47

Dividend Yield

4.07%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Primary Health Properties PLC (PHP.L)?

The following Wall Street analysts have issued research reports on Primary Health Properties PLC (PHP.L) in the last year: Barclays PLC, Berenberg Bank, Jefferies Financial Group Inc., Liberum Capital, and Peel Hunt.
View the latest analyst ratings for PHP.

What is the current price target for Primary Health Properties PLC (PHP.L)?

4 Wall Street analysts have set twelve-month price targets for Primary Health Properties PLC (PHP.L) in the last year. Their average twelve-month price target is GBX 168, suggesting a possible upside of 10.5%. Peel Hunt has the highest price target set, predicting PHP will reach GBX 175 in the next twelve months. Berenberg Bank has the lowest price target set, forecasting a price of GBX 155 for Primary Health Properties PLC (PHP.L) in the next year.
View the latest price targets for PHP.

What is the current consensus analyst rating for Primary Health Properties PLC (PHP.L)?

Primary Health Properties PLC (PHP.L) currently has 2 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PHP will outperform the market and that investors should add to their positions of Primary Health Properties PLC (PHP.L).
View the latest ratings for PHP.

What other companies compete with Primary Health Properties PLC (PHP.L)?

Other companies that are similar to Primary Health Properties PLC (PHP.L) include Chartwell Retirement Residences, NorthWest Health Prop Real Est Inv Trust, Assura, Impact Healthcare REIT and Medicx Fund.

How do I contact Primary Health Properties PLC (PHP.L)'s investor relations team?

Primary Health Properties PLC (PHP.L)'s physical mailing address is 5th Fl, Greener House, 66-68 Haymarket, LONDON, SW1Y 4RF, United Kingdom. The real estate investment trust's listed phone number is +44-20-71045599. The official website for Primary Health Properties PLC (PHP.L) is www.phpgroup.co.uk.

LON:PHP - Primary Health Properties PLC (PHP.L) Stock Price Target and Predictions

Analyst Price Target for PHP

Past Monthly Recommendations

Latest Recommendations

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Primary Health Properties PLC (PHP.L)?

What is the current price target for Primary Health Properties PLC (PHP.L)?

What is the current consensus analyst rating for Primary Health Properties PLC (PHP.L)?

What other companies compete with Primary Health Properties PLC (PHP.L)?

How do I contact Primary Health Properties PLC (PHP.L)'s investor relations team?